Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of SUTENT in relapsed and/or metastatic squamous cell carcinoma of the head and neck
2006-001780-30Phase 2Completed
- Sponsor
- Cliniques universitaires Saint-Luc
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sunitinib in head and neck squamous cell carcinoma (HNSCC), sponsored by Cliniques universitaires Saint-Luc. Primary endpoint: Objective response rate. Started Jan 2007; status: completed.
02
Drugs
sunitinib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on 2006-001780-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001780-30.